Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > バイオシミラー

Anti-Human B7-1/CD80 Reference Antibody (Galiximab, RUO) (HW630016)

Anti-Human B7-1/CD80 Reference Antibody (Galiximab, RUO)
Anti-Human B7-1/CD80 Reference Antibody (Galiximab, RUO)
Anti-Human B7-1/CD80 Reference Antibody (Galiximab, RUO)
Anti-Human B7-1/CD80 Reference Antibody (Galiximab, RUO)
価格(USD):
スペック:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号HW630016
説明
Galiximab (HW630016) is a research-grade recombinant antibody targeting CD80. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
種反応性Human
アプリケーションELISA, Bioactivity: FACS, Functional assay, Research in vivo
宿主種Chimeric
クローン性Monoclonal
アイソタイプIgG1-lambda
発現システム Mammalian cells
ターゲット CD80, BB1, T-lymphocyte activation antigen CD80, CD28LG, B7, CD28LG1, LAB7, Activation B7-1 antigen, CTLA-4 counter-receptor B7.1
エンドトキシンレベル < 10 EU/mg
純度 >95% purity as determined by SDS-PAGE.
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 P33681
形態 Liquid
保存バッファー 0.01M PBS pH 7.4

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
別名IDEC-114, 357613-77-5
背景

T-lymphocyte activation antigen CD80 (B7-1) is a ~33 kDa protein. Costimulatory molecule that belongs to the immunoglobulin superfamily that plays an important role in T-lymphocyte activation. Acts as the primary auxiliary signal augmenting the MHC/TCR signal in naive T-cells by acting as a ligand for the CD28 receptor which is constitutively expressed on the cell surface of T-cells. In turn, activates different signaling pathways such as NF-kappa-B or MAPK leading to the production of different cytokines. Also acts as an inhibitor of T-cell activation by acting as a ligand for CTLA4, a decoy receptor, thereby blocking CD28-mediated T-cell priming. In addition, CD28/CD80 costimulatory signal stimulates glucose metabolism and ATP synthesis of T-cells by activating the PI3K/Akt signaling pathway.

1. Lu, B. et al. (2024) Acta pharmacologica Sinica 45, 1214-1223. PMID: 38467718
2. Collins, AV. et al. (2002) Immunity 17, 201-10. PMID: 12196291
3. Boulougouris, G. et al. (1999) Journal of immunology (Baltimore, Md. : 1950) 163, 1809-16. PMID: 10438913
4. Vandenborre, K. et al. (1999) Immunology 98, 413-21. PMID: 10583602
5. Stamper, CC. et al. (2001) Nature 410, 608-11. PMID: 11279502
6. Frauwirth, KA. et al. (2002) Immunity 16, 769-77. PMID: 12121659
7. Kennedy, A. et al. (2023) The EMBO journal 42, e111556. PMID: 36727298
注意事項 For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1, lambda Isotype Control antibody (HyHEL-10) (HP248107)
イメージ
  • Anti-Human B7-1/CD80 Reference Antibody (Galiximab, RUO)

    Bioactivity

    Detects Human CD80/B7-1 in indirect ELISAs.

  • Anti-Human B7-1/CD80 Reference Antibody (Galiximab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Galiximab.

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト